[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352169-105":59,"doc-detail-352169-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","australian-pancreatic-cyst-registry-protocol-for-a-prospective-national-clinical-quality-registry-of-intraductal-papillary-mucinous-neoplasms","Australian Pancreatic Cyst Registry - protocol for a prospective national clinical quality registry of intraductal papillary mucinous neoplasms","","Intraductal papillary mucinous neoplasms (IPMNs) are common pancreatic cystic neoplasms with malignant potential. Existing IPMN management evidence largely comes from retrospective surgical cohorts, which over-represent high-risk cases and provide limited long-term insight for conservatively managed lesions. Australia lacks a prospective national dataset to evaluate surveillance pathways, practice patterns, guideline adherence, and long-term outcomes. The Australian Pancreatic Cyst Registry (APCR) addresses these evidence gaps.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/australian-pancreatic-cyst-registry-protocol-for-a-prospective-national-clinical-quality-registry-of-intraductal-papillary-mucinous-neoplasms/352169/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/australian-pancreatic-cyst-registry-protocol-for-a-prospective-national-clinical-quality-registry-of-intraductal-papillary-mucinous-neoplasms/352169.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the Australian Pancreatic Cyst Registry (APCR) address?","Question",{"text":113,"@type":114},"The APCR addresses evidence gaps in Australia by creating a prospective national dataset to evaluate surveillance pathways, practice patterns, guideline adherence, and long-term outcomes for individuals with IPMN.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is the APCR study designed and what data does it collect?",{"text":118,"@type":114},"The APCR is a prospective, multicentre clinical quality registry collecting clinical, imaging, management, and outcome data across public and private healthcare settings. Standardised electronic case report forms capture variables aligned with risk features described in the 2024 Kyoto guidelines.",{"name":120,"@type":111,"acceptedAnswer":121},"What recruitment model does the registry use and what is the follow-up scope?",{"text":122,"@type":114},"The registry uses an opt-out recruitment model aiming to enrol up to 10,000 participants over five years. Participants are followed through routine clinical care until discharge from surveillance, diagnosis of pancreatic cancer, withdrawal, or death.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352169,1790497944,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Open access Protocol  \n Australian Pancreatic Cyst Registry:  \nprotocol for a prospective national clinical quality registry of intraductal papillary mucinous neoplasms  \nAshleigh R Poh  ,1 Raffiela Garcia,1 Rebekah De Losa,1 Natalie Heriot,1 Caroline P Le,1,2 Lynn Chong,3 Eunice Lim,3 Haroon Gill,4 Lizzy Chooi,4  \nCham Bulathsinghalag,5 Simon Banting,3 Daniel G Croagh  ,3,5 Brett Knowles,3,6 Luke Bradshaw,4,7 Santhi Swaroop Vege,8 Adrian Fox,3,4 Andrew J Metz1,9  \nTo cite: Poh AR, Garcia R, De Losa R, et al. Australian Pancreatic Cyst Registry:  \nprotocol for a prospective national clinical quality registry of intraductal papillary mucinous neoplasms. BMJ Open 2026;16:e123505 . doi:10 . 1136/ bmjopen-2026-123505  \n► Prepublication history for this paper is available online. To view these files, please visit the journal online ([https://doi](https://doi). org/10 . 1136/bmjopen-2026- 123505) .  \nARP, RG and RDL contributed equally.  \nAF and AJM contributed equally.  \nReceived 01 June 2026 Accepted 27 August 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nAshleigh R Poh;  \n[ashleigh.poh@epworth.org.au](ashleigh.poh@epworth.org.au)  \nABSTRACT  \nIntroduction Intraductal papillary mucinous neoplasms (IPMNs) are common pancreatic cystic neoplasms  \nwith malignant potential. Current evidence on IPMN management is derived largely from retrospective surgical cohorts that over-represent high-risk cases and provide limited insight into the long-term outcomes of conservatively managed lesions. Australia currently lacksa prospective national dataset to evaluate surveillance pathways, practice patterns, guideline adherence and long-term outcomes in individuals with IPMN. Variation between international guideline recommendations may also contribute to differences in surveillance intensity and thresholds for intervention. The Australian Pancreatic Cyst Registry (APCR) was established to address these evidence gaps.  \nMethods and analysis The APCR is a prospective, multicentre clinical quality registry that collects clinical, imaging, management and outcome data for individuals with IPMN across public and private healthcare settings in Australia. Historical information is extracted from existing clinical documentation where available, with prospective data collection continuing during routine follow-up. The registry operates under an opt-out model and aims to enrol up to 10 000 participants over a 5-year recruitment period. Participants are followed through routine clinical care until discharge from surveillance, diagnosis of pancreatic cancer, withdrawal or death. Standardised electronic case report forms capture clinical and imaging variables aligned with risk features described in the 2024 Kyoto guidelines. This analysis will describe participant characteristics, cyst features, management and clinical outcomes, with comparative, time-to-event and multivariable analyses undertaken where appropriate. Guideline adherence and the predictive performance of established risk stratification frameworks will also be evaluated.  \nEthics and dissemination The study protocol was approved by the Monash Health Human Research Ethics Committee (Project ID: RES-24-0000-634A) . Findings will be disseminated through peer-reviewed publications, conference presentations and updates to participating sites.  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ The prospective, multicentre design collects longitudinal data from routine clinical care across public and private healthcare settings.  \n⇒ The opt-out recruitment model allows broad inclusion of eligible patients identified through routine clinical pathways across participating sites.  \n⇒ Standardised electronic case report forms capture predefined clinical and imaging variables aligned with risk features described in the 2024 Kyoto guidel","cbCaikVCdhH4Y1y0","https://ap.wps.com/l/cbCaikVCdhH4Y1y0","pdf",768264,"English","# Abstract\n## Introduction\n## Methods and analysis\n## Ethics and dissemination\n# Strengths and limitations of this study\n# Background","[{\"question\":\"What problem does the Australian Pancreatic Cyst Registry (APCR) address?\",\"answer\":\"The APCR addresses evidence gaps in Australia by creating a prospective national dataset to evaluate surveillance pathways, practice patterns, guideline adherence, and long-term outcomes for individuals with IPMN.\"},{\"question\":\"How is the APCR study designed and what data does it collect?\",\"answer\":\"The APCR is a prospective, multicentre clinical quality registry collecting clinical, imaging, management, and outcome data across public and private healthcare settings. Standardised electronic case report forms capture variables aligned with risk features described in the 2024 Kyoto guidelines.\"},{\"question\":\"What recruitment model does the registry use and what is the follow-up scope?\",\"answer\":\"The registry uses an opt-out recruitment model aiming to enrol up to 10,000 participants over five years. Participants are followed through routine clinical care until discharge from surveillance, diagnosis of pancreatic cancer, withdrawal, or death.\"}]","Australian Pancreatic Cyst Registry - protocol for a prospective national clinical quality registry of intraductal papillary mucinous neoplasms | PDF",1790098059,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3eec59fb2a23e3d350d2bb827218378.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/145f5c68eeb1eed0d4da10c6da54022b.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6eacc300d47a4d75e595474acb2266fe.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec7159b00ce96b6d968deabf5d49200c.webp",980,1306]